Connect with us
Information

NORTH AMERICA EDITION
Australia
North America
World

Investing News NetworkYour trusted source for investing success

NORTH AMERICA EDITION
North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

Psychedelics Market

Psychedelics News

Psychedelics Stocks

Psychedelics Market
Psychedelics News
Psychedelics Stocks

Psychedelics Investing

Psychedelic mushrooms.

Psychedelics Investing

Psychedelics Market Update: H1 2024 in Review

Aug 1, 2024 01:15PM PST

The psychedelics sector continues to attract investor attention. What trends moved the market in the first half of 2024?

psychedelics investing psychedelics outlook Psychedelics Investing

Latest Articles

FDA Finds Kratom Capsules Safe, but Questions About Concentrated Forms Remain

psychedelics investing Psychedelics Investing

Sep 20, 2024 09:15AM PST

Psychedelics Market Forecast: Top Trends That Will Affect Psychedelics in 2024

psychedelics investing psychedelics outlook Psychedelics Investing

Jan 11, 2024 01:15PM PST

Psychedelics Market 2023 Year-End Review

psychedelics stocks psychedelics investing psychedelics outlook Psychedelics Investing

Jan 10, 2024 01:15PM PST

How to Invest in Psychedelics

psychedelics stocks psychedelics investing psychedelics outlook Psychedelics Investing

Melissa Pistilli

Aug 29, 2023 01:15PM PST

Psychedelics Stocks to Watch

psychedelics stocks psychedelics investing cse stocks Psychedelics Investing

Bryan Mc Govern

May 8, 2023 01:15PM PST

Psychedelics Market Forecast: 3 Top Trends That Will Affect Psychedelics in 2023

psychedelics investing psychedelics outlook trading finance Psychedelics Investing

Bryan Mc Govern

Dec 22, 2022 01:15PM PST

More Articles

Company Profiles

CEO Interviews

Silo Wellness CEO Sees Market Traction for Psychedelic Healing

psychedelics investing cse stocks cse:silo Psychedelics Investing

Investing News Network

Jun 1, 2023 01:00PM PST

Orphan Drug Development an Exciting Opportunity to Provide Superior Therapeutics, Lobe Sciences CEO Says

pharmaceutical investing cse:lobe psychedelics investing cse stocks Pharmaceutical Investing

Investing News Network

Apr 27, 2023 01:00PM PST

Albert Labs Eyes One Dose Psilocybin Treatment for Cancer-related Anxiety

pharmaceutical investing psychedelics investing cse stocks cse:abrt Psychedelics Investing

Investing News Network

Apr 25, 2023 01:00PM PST

More CEO Interviews

Trending

Functional Mushrooms: A Market Overview

pharmaceutical investing psychedelics investing pharmaceutical stocks psychedelics stocks Pharmaceutical Investing

Investing News Network

May 30, 2024 01:00PM PST

The Business Case for Vertical Integration

pharmaceutical investing psychedelics investing pharmaceutical stocks Pharmaceutical Investing

Investing News Network

May 23, 2024 01:00PM PST

Functional Mushrooms: A Growing Opportunity

pharmaceutical investing psychedelics investing Pharmaceutical Investing

Investing News Network

May 16, 2024 01:00PM PST

More Trending Articles

psychedelics News

Quantum Biopharma Announces Completion of the Phase 1 Multiple Ascending Dose Clinical Trial for its Experimental Multiple Sclerosis Drug Lucid-21-302

Feb 26, 2025 04:17PM PST

Fungtional Labs

Fungtional Labs: Integrated Supply Chain for Mushroom Cultivators in North America

Pharmaceutical Investing

May 15, 2024 07:02AM PST

Lobe Sciences Provides Update on L-130 Clinical Program

Psychedelics Investing

Dec 7, 2023 02:00AM PST

Lobe Sciences Provides Update on L-130 Oral Psilocin Compound

Psychedelics Investing

Dec 5, 2023 01:30AM PST

TSX Venture Exchange Stock Maintenance Bulletins

Life Science Investing

Oct 26, 2023 02:54PM PST

Lobe Sciences (CSE:LOBE)

Lobe Sciences, Ltd. Announces The Appointment Of Mathew Lee As CFO

Psychedelics Investing

Sep 18, 2023 07:44AM PST

Lobe Sciences (CSE:LOBE)

Lobe Sciences, Ltd. Announces Amendment to the Acquisition of Altemia & Company

Psychedelics Investing

Sep 14, 2023 01:00PM PST

Silo Wellness (CSE:SILO)

Silo Wellness Announces LOI to Acquire NUGL/Kaya in a Transaction Valued at CAD $43,289,624.60; CSE to Halt Trading Until Shareholder Approval

Life Science Investing

Aug 29, 2023 12:05AM PST

Silo Wellness (CSE:SILO)

Milestone in Psychedelic Wellness: Silo Wellness and NUGL's Share Exchange Paves Way for Expansion and Collaboration

Life Science Investing

Aug 3, 2023 12:02AM PST

Silo Wellness (CSE:SILO)

Jamaica Based Kaya Group Forges Partnership with Silo Wellness for Psychedelic Wellness Experiences and Retreats; Announces Share Exchange Agreement

Life Science Investing

Aug 3, 2023 12:02AM PST

International

Emyria Limited (ASX:EMD)

Emyria and UWA in Partnership to Commercialise Novel Serotonin-Releasing Agents for Mental Health and Neurology

Psychedelics Investing

Oct 30, 2024 07:48PM PST

Melodiol Global Health (ASX:ME1)

Quarterly Activities Report: Melodiol Delivers $9.3m in Revenue During H1 FY24 – a 33% Increase the PCP

Psychedelics Investing

Jul 31, 2024 01:15AM PST

Melodiol Global Health Limited (ASX:ME1)

Corporate Update

psychedelics investing

Jul 29, 2024 05:23PM PST

Melodiol Global Health Limited (ASX:ME1)

Melodiol Global Health Limited (ASX: ME1) – Trading Halt

psychedelics investing

Jul 25, 2024 04:54PM PST

Melodiol Global Health Limited (ASX:ME1)

Mernova Q3 Revenue Update

psychedelics investing

Jul 23, 2024 04:41PM PST

More psychedelics News

Editors' Picks

Psychedelics Investing

Dec 20, 2022

Psychedelics Market 2022 Year-End Review

Psychedelics Investing

Nov 30, 2022

How Do Psychedelics Clinical Trials Work?

Psychedelics Investing

Aug 3, 2022

Morgan Stanley Positive in First Psychedelics Research Report

More Editors' Picks

Latest psychedelics News

More psychedelics News

Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.